Walleye Capital
ALT icon

Walleye Capital’s Altimmune ALT Stock Holding History

Walleye Capital’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6 Sell
2
-65,663
-100% -$279K ﹤0.01% 4313
2025
Q4 		$237K Buy
65,665
+50,147
+323% +$219K ﹤0.01% 3449
2025
Q3 		$58.5K Buy
+15,518
New +$59.9K ﹤0.01% 3953
2025
Q1 		– Sell
-22,224
Closed -$160K – 4193
2024
Q4 		$160K Buy
+22,224
New +$170K ﹤0.01% 3893
2024
Q3 		– Sell
-23,000
Closed -$153K – 5220
2024
Q2 		$153K Sell
23,000
-11,813
-34% -$87.2K ﹤0.01% 4475
2024
Q1 		$354K Buy
34,813
+11,206
+47% +$114K ﹤0.01% 3508
2023
Q4 		$266K Buy
+23,607
New +$98.6K ﹤0.01% 3469
2023
Q3 		– Sell
-419,783
Closed -$1.48M – 4830
2023
Q2 		$1.48M Buy
419,783
+372,544
+789% +$1.67M 0.01% 1541
2023
Q1 		$199K Buy
+47,239
New +$561K ﹤0.01% 2475
2022
Q3 		– Sell
-134,993
Closed -$1.99M – 3201
2022
Q2 		$1.58M Sell
134,993
-76,760
-36% -$473K 0.04% 443
2022
Q1 		$1.29M Buy
211,753
+139,449
+193% +$1.03M 0.03% 513
2021
Q4 		$662K Buy
+72,304
New +$768K 0.02% 808

Other funds holding ALT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Walleye Capital's ALT Position: Q1 2026 in Review

Walleye Capital reduced its Altimmune (ALT) stake by 100% in Q1 2026, selling an estimated $279K and leaving 2 shares worth $6. The position accounts for ﹤0.01% of the portfolio, ranked #4313.

Walleye Capital first reported a position in ALT in Q4 2021 and has held it in 12 quarters since. The position peaked at $1.58M in Q2 2022. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

  • Walleye Capital held 2 shares of Altimmune worth $6 as of Q1 2026.
  • Walleye Capital sold 65,663 Altimmune shares in Q1 2026, an estimated $279K.
  • Altimmune made up ﹤0.01% of Walleye Capital's portfolio in Q1 2026, its #4313 holding.
  • Walleye Capital first reported a position in Altimmune in Q4 2021 and has held it in 12 quarters since.
  • Walleye Capital's Altimmune position peaked at $1.58M in Q2 2022.
  • 173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Walleye Capital's 13F filing for Q1 2026, filed 11 May 2026.